Obesity News

An analysis of global conversations involving more than 1,600 health care professionals on social media in November has revealed collective optimism in response to the approval of a new weight-management option for adults with obesity.

The AMA has adopted a policy in support of insurance coverage parity for evidence-based weight-loss medications “without exclusions or additional carve-outs,” the organization recently announced.

Adolescents and young adults who partake in more light physical activity have lower cholesterol levels, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

Continued treatment with the GIP/GLP-1 dual agonist tirzepatide is necessary to maintain weight loss for adults with obesity, according to findings from the SURMOUNT-4 trial published in JAMA.

Findings from two cardiovascular outcome trials revealed that targeting obesity could become a major focus for treating cardiovascular disease and heart failure with preserved ejection fraction in the future, according to a speaker.

Adults with obesity can lose 15% or more of their body weight with nutrient-stimulated hormone-based therapies, but reducing body weight is not the only goal providers should have when treating obesity, according to a speaker.

The development of incretin-based molecules has led to therapies that can induce greater reductions in HbA1c and body weight for people with type 2 diabetes and obesity than other classes of medication, according to a speaker

Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.

As the first point of contact for many patients, it is important for primary care physicians to have strategies that will help treat and manage overweight and obesity, according to experts.

The U.S. Preventive Services Task Force has issued a draft recommendation encouraging physicians to provide or refer youth aged 6 years and older with a high BMI to intensive, comprehensive behavioral interventions.